Anb Bank »

Bridgebio Pharma shares owned by Anb Bank

Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by Anb Bank from 13F filings

Historical chart of Anb Bank investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Anb Bank consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Anb Bank

Quarter filed Position value Share count Share price at filing
2026-03-31 $211k 2.8k 74.26

More positions owned by Anb Bank

iShares S&P MidCap 400 Index (IJH)
Spdr S&p 500 Etf (SPY)
iShares Russell 2000 Index (IWM)
iShares MSCI EAFE Index Fund (EFA)
Apple (AAPL)
Alphabet Inc Class C cs (GOOG)
Microsoft Corporation (MSFT)
Berkshire Hathaway (BRK.B)
iShares S&P SmallCap 600 Index (IJR)
Visa (V)
Johnson & Johnson (JNJ)
Chevron Corporation (CVX)
NVIDIA Corporation (NVDA)
iShares S&P MidCap 400 Growth (IJK)
Amazon (AMZN)

View all positions for Anb Bank

Top funds holding Bridgebio Pharma

Vanguard Group
BlackRock
Kohlberg Kravis Roberts & Co
Henderson Group
Viking Global Investors
Farallon Capital Management
Vanguard Portfolio Management
Vanguard Capital Management
UBS Group
Aisling Capital Management
State Street Corporation
Jane Street
Geode Capital Management
Invesco
Susquehanna International

View all funds holding Bridgebio Pharma